SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis
BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR
SVS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. SVS has only an average score on both its financial health and profitability. SVS is growing strongly while it also seems undervalued. This is an interesting combination
1. Profitability
1.1 Basic Checks
SVS had positive earnings in the past year.
SVS had a positive operating cash flow in the past year.
Each year in the past 5 years SVS has been profitable.
SVS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 3.44%, SVS perfoms like the industry average, outperforming 52.54% of the companies in the same industry.
SVS's Return On Equity of 9.25% is fine compared to the rest of the industry. SVS outperforms 69.49% of its industry peers.
SVS has a better Return On Invested Capital (7.57%) than 72.88% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SVS is below the industry average of 8.57%.
The 3 year average ROIC (6.10%) for SVS is below the current ROIC(7.57%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.44% | ||
| ROE | 9.25% | ||
| ROIC | 7.57% |
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
1.3 Margins
SVS has a Profit Margin (4.49%) which is in line with its industry peers.
In the last couple of years the Profit Margin of SVS has grown nicely.
The Operating Margin of SVS (8.07%) is comparable to the rest of the industry.
SVS's Operating Margin has improved in the last couple of years.
SVS's Gross Margin of 25.79% is on the low side compared to the rest of the industry. SVS is outperformed by 84.75% of its industry peers.
SVS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.07% | ||
| PM (TTM) | 4.49% | ||
| GM | 25.79% |
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
2. Health
2.1 Basic Checks
SVS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
SVS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SVS has been reduced compared to 5 years ago.
SVS has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.86 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SVS has a Altman-Z score of 1.86. This is comparable to the rest of the industry: SVS outperforms 47.46% of its industry peers.
SVS has a debt to FCF ratio of 1707.47. This is a negative value and a sign of low solvency as SVS would need 1707.47 years to pay back of all of its debts.
With a Debt to FCF ratio value of 1707.47, SVS perfoms like the industry average, outperforming 47.46% of the companies in the same industry.
SVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating SVS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.64, SVS is not doing good in the industry: 71.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 1707.47 | ||
| Altman-Z | 1.86 |
ROIC/WACC1.08
WACC7.01%
2.3 Liquidity
A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.96, SVS is in line with its industry, outperforming 57.63% of the companies in the same industry.
SVS has a Quick Ratio of 1.42. This is a normal value and indicates that SVS is financially healthy and should not expect problems in meeting its short term obligations.
SVS has a better Quick ratio (1.42) than 67.80% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
SVS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.52%, which is quite impressive.
Measured over the past years, SVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.81% on average per year.
SVS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.19%.
Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.34% on average per year.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
3.2 Future
SVS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.90% yearly.
The Revenue is expected to grow by 8.45% on average over the next years. This is quite good.
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 7.78 indicates a rather cheap valuation of SVS.
100.00% of the companies in the same industry are more expensive than SVS, based on the Price/Earnings ratio.
SVS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.35.
Based on the Price/Forward Earnings ratio of 6.05, the valuation of SVS can be described as very cheap.
98.31% of the companies in the same industry are more expensive than SVS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.19. SVS is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.78 | ||
| Fwd PE | 6.05 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SVS indicates a rather cheap valuation: SVS is cheaper than 94.92% of the companies listed in the same industry.
SVS's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1195.27 | ||
| EV/EBITDA | 3.54 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SVS may justify a higher PE ratio.
A more expensive valuation may be justified as SVS's earnings are expected to grow with 16.90% in the coming years.
PEG (NY)0.38
PEG (5Y)0.34
EPS Next 2Y22.24%
EPS Next 3Y16.9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.15%, SVS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.07, SVS pays a better dividend. On top of this SVS pays more dividend than 88.14% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, SVS pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.15% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y22.24%
EPS Next 3Y16.9%
BIT:SVS (6/19/2025, 7:00:00 PM)
7.94
-0.24 (-2.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.46M
Analysts80
Price Target13.87 (74.69%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.15% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.78 | ||
| Fwd PE | 6.05 | ||
| P/S | 0.37 | ||
| P/FCF | 1195.27 | ||
| P/OCF | 7.26 | ||
| P/B | 0.75 | ||
| P/tB | 0.94 | ||
| EV/EBITDA | 3.54 |
EPS(TTM)1.02
EY12.85%
EPS(NY)1.31
Fwd EY16.54%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.77%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.34
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.44% | ||
| ROE | 9.25% | ||
| ROCE | 9.95% | ||
| ROIC | 7.57% | ||
| ROICexc | 11.41% | ||
| ROICexgc | 13.88% | ||
| OM | 8.07% | ||
| PM (TTM) | 4.49% | ||
| GM | 25.79% | ||
| FCFM | 0.03% |
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.64 | ||
| Debt/FCF | 1707.47 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 118.33% | ||
| Cap/Sales | 5.01% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 40.95% | ||
| Profit Quality | 0.68% | ||
| Current Ratio | 1.96 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 1.86 |
F-Score8
WACC7.01%
ROIC/WACC1.08
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%